A Study of BMS-986207 Given Alone and in Combination With Nivolumab or With Nivolumab and Ipilimumab in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Real-Life Study With Nivolumab (BMS-936558) in Advanced NSCLC Patients After Prior Chemotherapy
- Status
- COMPLETED
- Phase
- N/A
A Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
A Phase II Trial If Nivolumab, Lenalidomide and Dexamethasone in High Risk Smoldering Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Safety and Pharmacokinetics of BMS-986177 in Participants With End-stage Renal Dysfunction on Chronic Stable Hemodialysis Treatment
- Status
- COMPLETED
- Phase
- PHASE1
Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Phase 1 Study of Mesothelin-ADC
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetics and Metabolism Study of Radiolabeled BMS-986142 in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastatic or Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE3
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE4
Immune Checkpoint Inhibition in Combination With Radiation Therapy in Pancreatic Cancer or Biliary Tract Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Regression of Liver Fibrosis After Daclatasvir and Asunaprevir Treatment
- Status
- UNKNOWN
- Phase
- N/A
Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation Exposure
- Status
- TERMINATED
- Phase
- PHASE2
Single Ascending Dose and Multiple Ascending Dose Study in Healthy Participants and Proof of Mechanism Study in Patients With Ulcerative Colitis
- Status
- TERMINATED
- Phase
- PHASE1